Saleem Alinur, Sharon Lee, and Lorene Perona from ScionHealth's Kindred Hospitals discuss the importance of helping medically complex patients discharge to home after a hospital stay, and how Kindred is achieving this goal.
Saleem Alinur, Sharon Lee, and Lorene Perona from ScionHealth's Kindred Hospitals discuss the importance of helping medically complex patients discharge to home after a hospital stay, and how Kindred is achieving this goal.
Dean French, MD, EVP and CMO, of ScionHealth, parent company of Kindred Hospitals, and Saleem Alinur, VP of Managed Care, offer insight into the benefits of transferring septic patients to long-term acute care hospitals as soon as possible,...
Dean French, MD, EVP and CMO, of ScionHealth, parent company of Kindred Hospitals, and Saleem Alinur, VP of Managed Care, offer insight into the benefits of transferring septic patients to long-term acute care hospitals as soon as possible,...
Saleem Alinur and Sharon Lee, vice presidents of managed care at Kindred Hospitals, discuss the benefits of payers and health plans partnering with LTACHs to meet their goals of improving population health, patient experience, and cost...
Saleem Alinur and Sharon Lee, vice presidents of managed care at Kindred Hospitals, discuss the benefits of payers and health plans partnering with LTACHs to meet their goals of improving population health, patient experience, and cost...
Saleem Alinur and Sharon Lee, vice presidents of managed care at Kindred Hospitals, share strategies for improving outcomes for medically complex patients, emphasizing how care coordination meetings at the LTACH level can benefit both payers...
Saleem Alinur and Sharon Lee, vice presidents of managed care at Kindred Hospitals, share strategies for improving outcomes for medically complex patients, emphasizing how care coordination meetings at the LTACH level can benefit both payers...
Sean Muldoon, MD, SVP and Chief Medical Officer at Kindred Hospitals, discusses how MCG Health’s guideline revisions are improving ventilated patients’ access to LTACHs and why this is important for their recovery.
Sean Muldoon, MD, SVP and Chief Medical Officer at Kindred Hospitals, discusses how MCG Health’s guideline revisions are improving ventilated patients’ access to LTACHs and why this is important for their recovery.
Audra Early, senior vice president of strategy and network development, Kindred Hospitals, discusses the role of long-term acute care hospitals (LTACHs) in patient recovery, how LTACHs alleviated burden during the COVID-19 pandemic, and how...
Audra Early, senior vice president of strategy and network development, Kindred Hospitals, discusses the role of long-term acute care hospitals (LTACHs) in patient recovery, how LTACHs alleviated burden during the COVID-19 pandemic, and how...
Kaleb Kuhl, vice president of sales, Olio Health, discusses the cost variations associated with postacute care, the role of value-based care strategies, and what payers and accountable care organizations should know about managing patients...
Kaleb Kuhl, vice president of sales, Olio Health, discusses the cost variations associated with postacute care, the role of value-based care strategies, and what payers and accountable care organizations should know about managing patients...
Sean Muldoon, MD, MPH, FCCP, SVP and chief medical officer, Hospital Division, Kindred Hospitals, identifies the major differences between long-term acute care hospitals vs traditional hospitals, and compares the varied lengths of stay for...
Sean Muldoon, MD, MPH, FCCP, SVP and chief medical officer, Hospital Division, Kindred Hospitals, identifies the major differences between long-term acute care hospitals vs traditional hospitals, and compares the varied lengths of stay for...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate and Editorial Board Member of First Report Managed Care—explores newly approved and existing anticoagulant therapies. He analyzes...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate and Editorial Board Member of First Report Managed Care—explores newly approved and existing anticoagulant therapies. He analyzes...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
